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Cognitive dysfunction at high altitude (HA) may result from suboptimal matching of oxygen supply to
neural demand (i.e. neurovascular coupling [NVC]). NVC is modulated by nitric oxide (NO) which
initially decreases at HA. PURPOSE: Investigate the effect of NO-donor (nitrate) supplementation on
NVC and cognitive function at HA. METHODS: 20 healthy men (23±3 yrs, BMI 24.3±3.0 kg∙m-2)
participated in this randomized, double-blind, crossover design study on two separate days. Following sea
level (SL) cognitive/NVC testing, participants consumed either nitrate (NIT) or a NIT-depleted placebo
(PLA). Participants then underwent 120 minutes of HA (11.5±0.2% O2) and all cognitive/NVC testing
was repeated. NVC was assessed by measuring the change in mean middle cerebral artery (MCA) blood
flow velocity during a cognitive challenge (incongruent Stroop task) using transcranial Doppler.
Additional cognitive testing targeted the memory and executive function domains using memory
recognition, maze, and choice reaction tasks. Brachial artery flow-mediated dilation (FMD) and salivary
nitrite were assessed as systemic proxies of NO-metabolism. RESULTS: Salivary nitrite significantly
increased following supplementation at HA for NIT compared to PLA (p<0.05). FMD and memory
performance significantly decreased and executive function, reaction time and MCA reactivity were
unchanged at HA in both conditions (p>0.05). CONCLUSION: NIT significantly increased salivary
nitrite levels at HA compared to PLA. However, NIT was unable to prevent reductions in FMD or
decreased memory at HA nor was NIT able to augment NVC at HA compared to SL.
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Table 1. NO-metabolism, cognitive function, and NVC at SL and HA between conditions (mean ± SD)
Placebo (PLA)
Nitrate (NIT)
SL
HA
SL
HA
SaO2 (%)
98 ± 2
75 ± 6*
98 ± 2
75 ± 7*
FMD (%)
6.22 ± 3.62
4.87 ± 3.22*
8.13 ± 3.14
5.52 ± 3.14*
Salivary nitrite (AU)
0.1 ± 0.2
0.2 ± 0.3
0.1 ± 0.2
2.7 ± 1.0†*
NVC
∆MCA Mean velocity (cm∙s-1)
+5±6
+5±9
+7±7
+6±7
Cognitive measures
Verbal memory indexa
75 ± 9
70 ± 10*
75 ± 5
71 ± 10*
Maze accuracy
30 ± 14
28 ± 11
29 ± 12
31 ± 10
343.35 ±
Choice reaction time (ms)
346.52 ± 31.85 328.72 ± 34.56 350.52 ± 26.52
73.64
SL, sea level; HA, high altitude; SaO2, arterial oxygen saturation; FMD, flow mediated dilation; MCA,
middle cerebral artery.
a
calculated as (immediate memory recognition + delayed memory recognition)
*p<0.05 vs SL; †p<0.05 vs PLA

